Cargando…
From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman
Irv Weissman has pursued many areas of biomedical research throughout his prolific career as a medical doctor and researcher. In this interview, he recalls his early years studying immunology in mice, and discusses the more recent challenges he has faced when attempting to develop stem-cell-based th...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Company of Biologists Limited
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180217/ https://www.ncbi.nlm.nih.gov/pubmed/21878457 http://dx.doi.org/10.1242/dmm.008532 |
| _version_ | 1782212598119268352 |
|---|---|
| collection | PubMed |
| description | Irv Weissman has pursued many areas of biomedical research throughout his prolific career as a medical doctor and researcher. In this interview, he recalls his early years studying immunology in mice, and discusses the more recent challenges he has faced when attempting to develop stem-cell-based therapies with industry. |
| format | Online Article Text |
| id | pubmed-3180217 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | The Company of Biologists Limited |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31802172011-09-30 From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman Dis Model Mech A Model For Life Irv Weissman has pursued many areas of biomedical research throughout his prolific career as a medical doctor and researcher. In this interview, he recalls his early years studying immunology in mice, and discusses the more recent challenges he has faced when attempting to develop stem-cell-based therapies with industry. The Company of Biologists Limited 2011-09 /pmc/articles/PMC3180217/ /pubmed/21878457 http://dx.doi.org/10.1242/dmm.008532 Text en © 2011. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms. |
| spellingShingle | A Model For Life From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title | From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title_full | From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title_fullStr | From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title_full_unstemmed | From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title_short | From immunological tolerance to stem cell therapy and back: an interview with Irving Weissman |
| title_sort | from immunological tolerance to stem cell therapy and back: an interview with irving weissman |
| topic | A Model For Life |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180217/ https://www.ncbi.nlm.nih.gov/pubmed/21878457 http://dx.doi.org/10.1242/dmm.008532 |